Drug Profile
LC 34AD3
Alternative Names: LC-34AD3Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for research development in Type-2-diabetes-mellitus in China
- 28 Aug 2015 Early research in Type-2 diabetes mellitus in China (unspecified route)